Overview
Arine provides a data-driven platform for personalized medication therapy management (MTM) that helps healthcare providers, insurers, and health plans manage complex regimens for older or high‑risk patients. The system analyzes a patient’s health profile, current medications, and risks to deliver comprehensive medication management, medication intelligence, and optimization services through a subscription. This approach emphasizes evidence-based, patient-specific care to improve safety and outcomes and to support performance metrics like CAHPS and Star ratings. The goal is to improve patient health while reducing overall healthcare costs for client organizations.
Work here?Claim your company
Simplify's take
What believers are saying
- Arine’s August 2026 blog cites a multi-state plan reducing utilization and costs.
- Arine says it produces forty million recommendations annually and reached three Inc. 5000 years.
- MDX Hawaii’s April 2025 partnership expands Arine into senior-care provider networks.
What critics are saying
- Arine depends on CMS Star Ratings economics, and 2026 rule changes compress differentiation.
- CVS Caremark, Optum, and ESI can bundle medication services with PBM contracts.
- If payer pilots fail to renew after 2026, Arine’s growth engine stalls.
What makes Arine unique
- Arine’s AI combines medication analytics with pharmacist-led interventions across 30 million lives.
- Town Hall Ventures backed Arine’s June 2025 Series C, validating payer-grade medication intelligence.
- HITRUST r2 certification and AWS hosting support enterprise trust for health plans.
Help us improve and share your feedback! Did you find this helpful?